spacer.png, 0 kB
spacer.png, 0 kB
 
 
Jazz Pharmaceuticals, Inc. Announces Submission Of Complete Responses To FDA Approvable Letters For. E-mail
Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the submission of the complete response by Solvay Pharmaceuticals, Inc. to the FDA approvable letter for Luvox(R) CR (fluvoxamine maleate) extended-release capsules. The PDUFA action date is December 22, 2007. [click link for full article]
Read more at: http://www.medicalnewstoday.com/articles/78670.php.
 
< Prev   Next >
Related Resources
spacer.png, 0 kB
spacer.png, 0 kB

Attack Panic is a resource for panic and anxiety disorders. Information on these pages is (C) AttackPanic.com. Disclaimer.